Hayward, California, April 12, 2004--Quantum Dot Corporation appointed George Dunbar as CEO and board director. Dunbar's experience includes more than 25 years as CEO, director, and senior manager with many private and public bioscience companies. Most recently he was CEO of Targesome; prior to Targesome, he was CEO of Epic Therapeutics, a controlled release formulation company sold to Baxter Healthcare in 2002. Dunbar's additional experience includes board and management positions at Molecular Probes, Amersham and Ares Serono.
Quantum Dot Corporation is a privately held bioscience company addressing markets in life science research, clinical diagnostics, and clinical imaging. The company manufactures quantum dot crystals, which act as miniature semiconductors and can be used to detect for specific proteins, primarily in the development of pharmaceuticals.